Mucosal vaccination delays or prevents prion infection via an oral route.
about
A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell linesActive and passive immunotherapy for neurodegenerative disordersThe Priority position paper: Protecting Europe's food chain from prionsClearance and prevention of prion infection in cell culture by anti-PrP antibodies.An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study.Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie.Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease.Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine.Prion protein-specific antibodies-development, modes of action and therapeutics applicationImmunomodulation for prion and prion-related diseases.Immunization with recombinant prion protein leads to partial protection in a murine model of TSEs through a novel mechanismNeoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice.Could immunomodulation be used to prevent prion diseases?Mechanistic insights into the cure of prion disease by novel antiprion compoundsPrion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies.Recent developments in mucosal vaccines against prion diseases.The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies.High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice.Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies.Detection and control of prion diseases in food animals.Therapeutic approaches for prion and Alzheimer's diseases.Therapeutic approaches for prion disorders.Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivoSmall-molecule theranostic probes: a promising future in neurodegenerative diseases.Therapeutic interventions ameliorating prion disease.Cross currents in protein misfolding disorders: interactions and therapy.Immunotherapy for prion diseases: opportunities and obstacles.Antibody-based therapy in Alzheimer's disease.Modelling neurodegeneration in prion disease - applications for drug development.Immunotherapeutic approaches in prion disease: progress, challenges and potential directions.DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge.Mechanisms of prion-induced neurodegeneration.Salmonella enterica serovar Typhimurium immunotherapy for B-cell lymphoma induces broad anti-tumour immunity with therapeutic effect.The Ecology of Prions.M cell-depletion blocks oral prion disease pathogenesis.Mucosal immunization with an attenuated Salmonella vaccine partially protects white-tailed deer from chronic wasting disease.Induction of PrPSc-specific systemic and mucosal immune responses in white-tailed deer with an oral vaccine for chronic wasting disease.How do PrPSc Prions Spread between Host Species, and within Hosts?Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice.
P2860
Q21562652-3D1C7D5D-7DE0-4C41-8153-353479632175Q24657879-0F3FE49A-7543-4890-A5D5-452DAF06074BQ28830533-40FE1B83-CBD2-4A3D-941C-B6E121901143Q33248701-7816CD6C-2216-4536-B5D3-9D6CA30A6D76Q33317534-7FA7784B-457C-47F7-A116-18EC2599CAA8Q33419380-4D6DB4F4-B6B4-497E-87BA-4A133B0C0C99Q33725397-84A32636-9BD9-4FC5-ABF4-6C5FE1D081AFQ33742312-F2EC3999-5E8D-4ABA-887C-E87DDED3B352Q34423386-B8B5BA71-71C7-4A50-9907-9D63AC1DEEE9Q34565644-07A96365-8A85-4D04-B5A8-D7CD5B7EAC81Q34648779-776B19D0-48E1-42C9-87CF-9544DAE8C7E5Q35766493-ACCE6781-D51D-4197-998D-7530FE53A9F4Q35875915-E36EB5CF-C105-453B-BE34-5CF20DDEC64CQ36099134-6A1E8EFA-1752-47CF-8A0A-F6B347DDACB6Q36407253-77E127C3-7F8C-445D-B84E-B01905B479EDQ36728797-C61BFDE9-DCC2-46E1-8579-21F3BC67D8B4Q36731460-9FB3D13B-0498-4107-BEFF-170901362A69Q36776046-7F571825-6B59-4264-8627-9E83E0AA83F7Q36780126-F71714A3-FE4F-437A-A688-4D79802DD9B0Q36857700-DC41BCDA-988F-4658-B977-9EE4B121FFAFQ36872884-3B458AE3-0DB7-4C08-9E05-5BEA41B3EB9DQ36901944-8B9AEA62-F286-4652-AAE6-610AD3C56237Q37191835-6B013B13-3C6E-4663-BA9F-C0E15E4D112FQ37267798-B84EA766-7BE3-46A0-B1CE-0E2B3973BD02Q37353880-8821BBA0-457C-41C3-AE2E-D4BD0754996BQ37557690-AF137056-B92B-4A70-8015-E510114F634DQ37585420-2FCBB131-A53B-48A6-8EB0-1070766B4A03Q37773260-CA4E616C-8893-4601-9D83-EB4528B09235Q37831912-C81CEA73-2C5A-4ADB-A0C0-B3EAF8C03D3CQ38089150-3CA9E1C6-153A-409F-B0CC-446887E7C387Q38104409-28AD49AF-E8EA-4635-BE08-9E9A2622E142Q38761934-B0B2A8A4-1522-4132-994D-A730A0C36C5AQ38800950-C279871E-C2C1-41AE-B0E8-D2D2A9446227Q38994432-EC544C8C-7467-4835-99B7-4F65C93271EBQ39342335-15D49B5A-8235-421F-9FD0-6D39EDCFF475Q41281065-22C456FB-E27C-4628-A6A0-C80989011BEBQ41582362-C96D0C52-4EAE-4466-A057-AFC9B0EC5252Q41992326-B01C5CF7-C67E-43D6-A28D-F5CA4499F921Q46251829-275F75DE-5CCF-4AA7-AA5F-B8D34BE21E3FQ49395392-FE6B420C-241D-4707-9135-C66BB07619E3
P2860
Mucosal vaccination delays or prevents prion infection via an oral route.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mucosal vaccination delays or prevents prion infection via an oral route.
@ast
Mucosal vaccination delays or prevents prion infection via an oral route.
@en
Mucosal vaccination delays or prevents prion infection via an oral route.
@nl
type
label
Mucosal vaccination delays or prevents prion infection via an oral route.
@ast
Mucosal vaccination delays or prevents prion infection via an oral route.
@en
Mucosal vaccination delays or prevents prion infection via an oral route.
@nl
prefLabel
Mucosal vaccination delays or prevents prion infection via an oral route.
@ast
Mucosal vaccination delays or prevents prion infection via an oral route.
@en
Mucosal vaccination delays or prevents prion infection via an oral route.
@nl
P2093
P1433
P1476
Mucosal vaccination delays or prevents prion infection via an oral route
@en
P2093
F Schreiber
H C Meeker
H Scholtzova
J A Chabalgoity
J Pankiewicz
P304
P356
10.1016/J.NEUROSCIENCE.2005.02.031
P407
P577
2005-01-01T00:00:00Z